Preventive measures significantly reduced the risk of nosocomial infection in elderly inpatients during the COVID‑19 pandemic

Wu, Shuangshuang; Li, Wen; Zhang, Mingjiong; Wang, Kai; Liu, Jin; Hu, Yujia; She, Quan; Li, Min; Shen, Shaoran; Chen, Bo; Wu, Jianqing

doi:10.3892/etm.2022.11499

Cited by 4 publications

(1 citation statement)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We observed a significant drop in the incidence of infections from 22.1% to 2.1% by wearing FFP2 masks by staff and patients. This underlines the efficacy of masking in reducing transmission of viral pathogens (13) in an inpatient setting. Puerta et.…”

Section: Discussionmentioning

confidence: 67%

The impact of FFP2 masking on medical wards for allogeneic hematopoietic stem cell transplantation: Retrospective analysis for future guidance

Richardson,

Holtick,

Scheid

et al. 2023

Preprint

View full text Add to dashboard Cite

Patients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT) are highly susceptible to infections. The use of masks on wards for allo-HSCT has been controversial in the past decades and was not common before the covid-19 pandemic. We retrospectively compared incidence and outcomes of viral respiratory infections during allo-HSCT on our specialized ward between 2018 – 2020 to the era of FFP2 masking between 2021 – 2023 covering similar seasons of the year. Each group consisted of 150 matched patients. The usage of FFP2 masks reduced the incidence of viral respiratory infections from 22,1% to 2,1% (p < 0.005). This reduced the time on ward from a median of 26 days to 23,5 days (p = 0,002). It also resulted in less use of CT-scans (p = 0.003) and bronchoalveolar lavage procedures (p = 0,057). Median time to proof of infection was 21 days after admission in both groups. No difference was detected in progression free survival, hospital survival or non-relapse mortality (p = 0,78). Our retrospective results indicate that FFP2 masks worn by patients and hospital staff significantly reduce the incidence of viral respiratory infections, including covid-19, shorten the time spent in hospital and reduce costs without affecting survival.

show abstract

Section: Discussionmentioning

confidence: 67%

The impact of FFP2 masking on medical wards for allogeneic hematopoietic stem cell transplantation: Retrospective analysis for future guidance

Richardson,

Holtick,

Scheid

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

Not only COVID-19: a systematic review of anti-COVID-19 measures and their effect on healthcare-associated infections

Ciccacci,

De Santo,

Mosconi

et al. 2024

Journal of Hospital Infection

View full text Add to dashboard Cite

Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation

Richardson,

Schütte,

Feyer

et al. 2024

Sci Rep

View full text Add to dashboard Cite

Patients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT) are highly susceptible to infections. The consequent use of masks on wards for allo-HSCT has been controversial in the past decades and was not common before the COVID-19 pandemic. We retrospectively compared incidence and outcomes of viral respiratory infections during allo-HSCT on our specialized ward between 01/2018 and 09/2020 to the era of FFP2 masking between 10/2020 and 10/2022 covering similar seasons of the year. Each group consisted of 150 matched patients. The usage of FFP2 masks reduced the incidence of viral respiratory infections from 22.1 to 2.1% (p < 0.005). This reduced the time on ward from a median of 26 days to 23.5 days (p = 0.002). It also resulted in less use of CT-scans (p = 0.003) and bronchoalveolar lavage procedures (p = 0.057). Median time to proof of infection was 21 days after admission in both groups. No difference was detected in progression free survival, hospital survival or non-relapse mortality (p = 0.78). Our retrospective results indicate that FFP2 masks worn by patients and hospital staff may help to significantly reduce the incidence of viral respiratory infections, including COVID-19, shorten the in-hospital time, and reduce costs without affecting survival.

show abstract

Preventive measures significantly reduced the risk of nosocomial infection in elderly inpatients during the COVID‑19 pandemic

Cited by 4 publications

References 72 publications

The impact of FFP2 masking on medical wards for allogeneic hematopoietic stem cell transplantation: Retrospective analysis for future guidance

The impact of FFP2 masking on medical wards for allogeneic hematopoietic stem cell transplantation: Retrospective analysis for future guidance

Not only COVID-19: a systematic review of anti-COVID-19 measures and their effect on healthcare-associated infections

Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation

Contact Info

Product

Resources

About